Skip to main content
main-content
Top

05-04-2018 | SGLT2 inhibitors | Review | Article

Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes

A systematic review and meta-analysis

Please follow the link below to view this article in full on a third party website. Note that a subscription or payment may be required.

https://doi.org/10.1001/jama.2018.3024

Related topics